Home › Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs
 

Keywords :   


Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs

2016-02-06 15:04:08| Biotech - Topix.net

's stock had its "neutral" rating reissued by research analysts at Goldman Sachs in a note issued to investors on Saturday, AnalystRatings.Net reports. They currently have a $56.00 target price on the stock, down from their previous target price of $60.00.

Tags: rating neutral goldman sachs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »